Company on-track to share Phase 2b data in 2H 2027 MIAMI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human ...
David Zaccardelli, Pharm.D. joins Board as ChairRita Jain, M.D., joins Board as an Independent DirectorMIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
On the surface, there seems to be little in common with a garment called the lungi and a sweet known as Rasmalai and yet ...
On the surface, there seems to be little in common with a garment called the lungi and a sweet known as Rasmalai and yet ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...
The built quality of tata is as usual top notch, the features and the look of the new punch is better than the older model.
In my marketing class, one of the examples I use to illustrate the activities of competitors is a scenario of a young man ...
$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...
Newly established Asset Management business launches 10 funds on Securities & Commodities Authority of the United Arab ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion ...
10d
BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board
BridGene Biosciences, Inc., a leader in the discovery of small-molecule drugs for traditionally "hard-to-drug" targets, announced today the appointment of Bruce A. Beutler, M.D., Nobel Prize--winning ...
In previous punch the first thing I didn't like was it's back light and its NA engine. Now it's going to slay all of it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback